follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Celegene gets FDA approval for Revlimid

By

Back to Top Comments Print

News You Can Use

Latest News

advertisement

Celgene Corp. on Wednesday announced it won Food and Drug Administration approval for Revlimid, a treatment for certain patients with mantle cell lymphoma.

According to a news release from Celgene, in Summit, the drug is approved for patients whose disease has relapsed or progressed after two prior therapies.

Write to the Editorial Department at editorial@njbiz.com

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top